Events

Brokerage Event NCP UK/KTN - Horizon Europe Consortia Building Event - Cluster 1 Health
JUN
Mon
14
09:00 - 17:00

This was 4 years ago

Location

Online

Programmes
Health

The UK National Contract Points (NCPs) in collaboration with the KTN Global Alliance are organising a Horizon Europe consortia building event on the Horizon Europe Health Cluster for potential applicants (in the UK, Europe and beyond).

This event focusses on those who have identified specific 2021 call topics or at least areas of interest in the draft Health Work Programme, and are ready to take the next steps, discussing concrete project ideas with potential partners and going forward to a proposal submission.

More detailed information about this online event and registration can be found here

 

 

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.